Splenectomy followed by administration of rituximab is useful to treat a patient with hairy cell leukemia-variant

被引：7
|
作者：
Yoshida, Tetsumi [1 ]
Mihara, Keichiro [1 ]
Sugihara, Sayaka [1 ]
Arihiro, Koji [2 ]
Mino, Tatsuji [1 ]
Sasaki, Naomi [3 ]
Takihara, Yoshihiro [4 ]
机构：
[1] Hiroshima Univ, Dept Hematol & Oncol, Res Inst Radiat Biol & Med, Minami Ku, Hiroshima 7348553, Japan
[2] Hiroshima Univ, Dept Pathol, Hiroshima 7348553, Japan
[3] Kure Kyosai Hosp, Dept Pathol, Kure, Japan
[4] Hiroshima Univ, Dept Stem Cell Biol, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan
来源：
ANNALS OF HEMATOLOGY | 2013年 / 92卷 / 05期
关键词：
Cladribine; Bone Marrow Involvement; Hairy Cell; Pentostatin; Atypical Lymphocyte;
D O I：
10.1007/s00277-012-1612-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：711 / 713
页数：3
相关论文
共 50 条
  • [1] Splenectomy followed by administration of rituximab is useful to treat a patient with hairy cell leukemia-variant
    Tetsumi Yoshida
    Keichiro Mihara
    Sayaka Sugihara
    Koji Arihiro
    Tatsuji Mino
    Naomi Sasaki
    Yoshihiro Takihara
    Annals of Hematology, 2013, 92 : 711 - 713
  • [2] Hairy-cell leukemia-variant treated with rituximab in an elderly patient.
    Shikara, MM
    Ramzan, M
    Chaudhri, F
    Aziz, AR
    BLOOD, 2003, 102 (11) : 309B - 309B
  • [3] Hairy cell leukemia-variant
    Al-Sheikh, IH
    Quadri, MI
    SAUDI MEDICAL JOURNAL, 2001, 22 (01) : 72 - 73
  • [4] Refractory hairy cell leukemia-variant
    Hu, Zhihong
    Sun, Yi
    Wang, Wei
    Medeiros, L. Jeffrey
    Kanagal-Shamanna, Rashmi
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (12) : 1398 - 1399
  • [5] Treatment of hairy cell leukemia-variant with cladribine
    Tetreault, SA
    Robbins, BA
    Saven, A
    LEUKEMIA & LYMPHOMA, 1999, 35 (3-4) : 347 - +
  • [6] Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant
    Wang, Yi
    Wang, Tingyu
    Yu, Ying
    Wang, Qi
    Yan, Yuting
    Li, Ru
    Sun, Qi
    Xiong, Wenjie
    Lyu, Rui
    Yu, Zhen
    Liu, Wei
    Sui, Weiwei
    Huang, Wenyang
    Wang, Huijun
    Li, Chengwen
    Wang, Jun
    Zou, Dehui
    An, Gang
    Wang, Jianxiang
    Qiu, Lugui
    Yi, Shuhua
    ANNALS OF HEMATOLOGY, 2022, 101 (06) : 1201 - 1210
  • [7] Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant
    Yi Wang
    Tingyu Wang
    Ying Yu
    Qi Wang
    Yuting Yan
    Ru Li
    Qi Sun
    Wenjie Xiong
    Rui Lyu
    Zhen Yu
    Wei Liu
    Weiwei Sui
    Wenyang Huang
    Huijun Wang
    Chengwen Li
    Jun Wang
    Dehui Zou
    Gang An
    Jianxiang Wang
    Lugui Qiu
    Shuhua Yi
    Annals of Hematology, 2022, 101 : 1201 - 1210
  • [8] Rituximab: a useful drug for a repeatedly relapsed hairy cell leukemia patient
    F. Pollio
    B. Pocali
    S. Palmieri
    P. Morabito
    G. Scalia
    L. Del Vecchio
    F. Ferrara
    Annals of Hematology, 2002, 81 : 736 - 738
  • [9] Rituximab: a useful drug for a repeatedly relapsed hairy cell leukemia patient
    Pollio, F
    Pocali, B
    Palmieri, S
    Morabito, P
    Scalia, G
    Del Vecchio, L
    Ferrara, F
    ANNALS OF HEMATOLOGY, 2002, 81 (12) : 736 - 738
  • [10] Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia-variant
    Locher, Maurus
    Jukic, Emina
    Bohn, Jan-Paul
    Untergasser, Gerold
    Steurer, Michael
    Cramer, Christian Andreas
    Schwendinger, Simon
    Vogi, Verena
    Verdorfer, Irmgard
    Witsch-Baumgartner, Martina
    Nachbaur, David
    Gunsilius, Eberhard
    Wolf, Dominik
    Zschocke, Johannes
    Steiner, Normann
    GENES CHROMOSOMES & CANCER, 2021, 60 (04): : 287 - 292
12345